MedTrace Logo

Direct Selective Laser Trabeculoplasty in Ethnic Chinese Population The Zhuiguang Trial

NCT05043831 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2023-05-12

No results posted yet for this study

Summary

The objective of this study is to evaluate the effectiveness (Intra-Ocular Pressure lowering) and safety of Direct Selective Laser Trabeculoplasty (DSLT) in ethnic Chinese subjects with Primary Open Angle Glaucoma or Ocular Hypertension.

Conditions

Interventions

DEVICE

DSLT

Direct-SLT is applied via the limbus to the trabecular meshwork

Sponsors & Collaborators

  • BelkinVision

    lead INDUSTRY

Principal Investigators

  • Sun Xinghuai, Prof. · Fundan University, Shanghai, China

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-15
Primary Completion
2023-01-15
Completion
2023-04-15

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05043831 on ClinicalTrials.gov